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 Summary 
Neural precursors in the developing olfactory epithelium (OE) give rise to three major neuronal 
classes – olfactory receptor (ORNs), vomeronasal (VRNs) and gonadotropin releasing hormone 
(GnRH) neurons. Nevertheless, the molecular and proliferative identities of these precursors are 
largely unknown. We characterized two precursor classes in the olfactory epithelium (OE) 
shortly after it becomes a distinct tissue at midgestation in the mouse: slowly dividing self-
renewing precursors that express Meis1/2 at high levels, and rapidly dividing neurogenic 
precursors that express high levels of Sox2 and Ascl1. Precursors expressing high levels of Meis 
genes primarily reside in the lateral OE, whereas precursors expressing high levels of Sox2 and 
Ascl1 primarily reside in the medial OE. Fgf8 maintains these expression signatures and 
proliferative identities. Using electroporation in the wild-type embryonic OE in vitro as well as 
Fgf8, Sox2 and Ascl1 mutant mice in vivo, we found that Sox2 dose and Meis1 – independent of 
Pbx co-factors – regulate Ascl1 expression and the transition from lateral to medial precursor 
state. Thus, we have identified proliferative characteristics and a dose-dependent transcriptional 
network that define distinct OE precursors: medial precursors that are most probably transit 
amplifying neurogenic progenitors for ORNs, VRNs and GnRH neurons, and lateral precursors 
that include multi-potent self-renewing OE neural stem cells.  INTRODUCTION 
The olfactory epithelium (OE) differentiates from the lateral surface ectoderm of the vertebrate 
head, and gives rise to three major neuron classes: olfactory receptor neurons (ORNs), 
vomeronasal receptor neurons (VRNs) and gonadotropin releasing hormone (GnRH) neurons. 
ORNs and VRNs detect and relay information about a vast range of chemicals essential for 
feeding, reproduction and social interactions (for reviews, see Ache and Young, 2005; Buck, 
2000; Dulac and Torello, 2003). GnRH neurons migrate from the OE to the hypothalamus 
(Schwanzel-Fukuda and Pfaff, 1989; Wray et al., 1989), where they regulate reproduction 
(Foster et al., 2006). Despite the functional importance of ORNs, VRNs and GnRH neurons, the 
identity of OE precursors remains uncertain. Furthermore, it is not know how local inductive 
signals or transcription factors distinguish proliferative and neurogenic capacities. Solving these 
longstanding mysteries not only provides insight into developmental specification of these 
essential yet inadequately characterized precursors, it addresses a central issue in regeneration: 
embryonic OE precursors must give rise to adult counterparts that generate ORNs and VRNs 
throughout life (reviewed by Schwob, 2002). Thus, we determined cellular and molecular 
mechanisms that define identity, proliferation and neurogenic potential of the earliest OE neural 
precursors.  
OE neuronal precursors, such as those in other nervous system regions (for reviews, see Gotz 
and Huttner, 2005; Jessell and Sanes, 2000; Livesey and Cepko, 2001), should be found in 
discrete locations, have characteristic gene expression, distinct proliferative kinetics and the 
unique capacity to generate all differentiated OE neuron classes. Cells expressing neurogenic 
bHLH transcription factors, particularly Ascl1, have been proposed as OE precursors (Beites et al., 2005; Cau et al., 1997); however, persistence of ORNs despite loss of Ascl1 function 
(Guillemot et al., 1993) indicates that other precursors can generate OE neurons. Accordingly, 
we determined relationships between additional transcription factors, and cells with distinct 
proliferative or differentiation capacity among the earliest OE precursors. We found substantial 
differences in OE precursor identity at midgestation: slowly dividing, self-renewing precursors 
expressing high levels of Meis genes populate primarily the lateral OE, whereas rapidly dividing 
neurogenic precursors expressing high levels of Sox2 and Ascl1 reside mostly in the medial OE. 
These identities are established in part by Fgf8, and a transcriptional network involving Sox2 
dose, Meis1 activity and Ascl1 expression that regulates progression from multipotent precursor 
to transit amplifying neuronal progenitor to post-mitotic neuron. Our findings suggest that 
among primarily lateral, Meis-expressing OE precursors are stem cells whose presence 
guarantees initial genesis of ORNs, VRNs and GnRH neurons.  
 
MATERIALS AND METHODS 
Animals 
Mouse embryos were harvested from timed-pregnant mothers (plug day=0.5) maintained by the 
Department of Laboratory Animal Medicine at the University of North Carolina at Chapel Hill or 
Children's Hospital (Boston, MA, USA). The Sox2 indicator (Ellis et al., 2004) was bred into 
CF-1 females from Sox2
eGFP/+ males. Fgf8
neo/neo (Meyers et al., 1998) and Ascl1
–/– embryos 
(Guillemot et al., 1993) were generated from Fgf8
neo/+ or Ascl1
+/– males and females, 
respectively. Sox2
hyp/– embryos were generated from Sox2
eGFP/+ males and Sox2
hyp/+ females (Taranova et al., 2006). Dams were killed by rapid cervical dislocation, and embryos were 
collected and genotyped using appropriate PCR primers. Institutional Animal Care and Use 
Committees (IACUC) at UNC-CH and CHB approved all procedures.  
Immunohistochemistry 
Embryos were fixed with 4% paraformaldehyde, embedded and cryosectioned using standard 
methods. Primary antibodies were obtained commercially [NCAM (Chemicon/Millipore), PH3 
(Chemicon/Millipore), TuJ1 (Babco), OMP (Wako), Pbx1/2/3, ACIIII (Santa Cruz), BrdU 
(Becton-Dickinson), IdU (Accurate Chemical and Scientific) and Ascl1 (Becton-Dickinson)] or 
as gifts [Meis1 and Meis2 (A. Buchberg, Thomas Jefferson University), and GnRH (S. Wray, 
NINDS)]. The Sox2 antiserum was produced by L. Pevny's laboratory, and TrpC2 antiserum by 
C. Dulac's laboratory. Images were obtained using a Leica DMR epifluorescence or Zeiss 
LSM510 laser-scanning confocal microscope.  
Cell cycle measurement 
We estimated cell cycle times using dual DNA synthesis labeling (Martynoga et al., 2005). 
Iodinated deoxyuridine (IdU) was injected initially (T0), intraperitoneally (i.p.; 70 mg/kg body 
weight) in pregnant dams followed by bromodeoxyuridine (BrdU; 50 mg/kg) 1.5 hours later 
(T1). After an additional 0.5 hours (T2), embryos are fixed for IdU/BrdU histochemistry. The 
mouse anti-BrdU antibody BrdU detects both IdU and BrdU; however, the rat anti-BrdU 
antibody is specific. Thus, cells remaining in S-phase during the 2-hour period are double-
labeled; IdU-labeled cells exit the cell cycle. S-phase (TS) and total cell cycle length (TC) is 
calculated as: TS=1.5/(number IdU labeled/number double-labeled cells), TC=TS/(number double-labeled/number all cells – identified by nuclear staining). We divided each OE section 
into ten sectors representing equivalent parts of its total length, and calculated TS and TC for 
each sector in a full series (7-10 sections) from five E11.5 embryos. Statistical analysis was 
performed using analysis of variance (ANOVA) followed by Tukey's honestly significant 
difference test.  
Short- and long-term BrdU labeling 
BrdU was injected i.p. at E9, E10 or E11, followed by 2-hour (DNA synthesis) or 5.5- to 6.5-day 
(birthdating) survival. For label retention, we adapted a long-term BrdU labeling protocol 
(Morshead et al., 1994); BrdU (50 mg/kg) was injected i.p. in pregnant dams at E9, with a 
second injection 4 hours later. Upon first injection, we provided 1 mg/ml BrdU as drinking 
water, and left this in place until E11.5. Thereafter, pregnancy continued, with no further BrdU 
exposure, until E16.5 when fetuses were collected for BrdU histochemistry.  
Pair cell assays 
The lateral and medial OE was microdissected from entire E11.5 litters (n=4 independent 
experiments/4 litters), and dissociated as described (Shen et al., 2002). Dissociated cells were 
plated at clonal density on poly-D lysine coated Terasaki plates. Some cell suspensions received 
Fgf8 (100 nM) prior to plating. Cultures were fixed after 20 hours, co-labeled for TuJ1 with 
Meis1 or Sox2, as well as bisbenzimide to identify nuclei. `Paired' bisbenzimide-labeled nuclei 
were identified in individual wells, and expression of neuronal and transcription factor markers 
was visualized and scored.  Explant electroporation, staining and analysis 
E11.5 lateral nasal processes (LNPs) were micro-dissected, and up to six LNPs at a time were 
transferred to an electroporation chamber (Protech International, San Antonio, TX) with 50 µl of 
3 mg/ml endotoxin-free control or Sox2, Meis1 or Meis1/Pbx1 DNA plasmids (Sigma) in HBSS 
(Invitrogen). LNP luminal (OE) surfaces were electroporated with five 50 ms pulses at 30 V 
separated by a 950 ms inter-pulse delay using an ECM 830 electroporator (BTX). LNPs were 
transferred to membrane filters (luminal surface up), grown 72 hours in vitro, fixed and 
immunostained (Tucker et al., 2006). Images of five non-overlapping fields were collected at 
63× from each explant with a Zeiss510 laser-scanning confocal microscope. Double-labeled cell 
frequencies were compared between conditions by a two-tailed unpaired Student's t-test.  
 
RESULTS 
Medial and lateral OE precursors are molecularly distinct 
At E11.5, shortly after the OE invaginates, graded expression of several transcription factors 
defines OE domains. Sox2, an essential SoxB1 factor in the OE (Donner et al., 2007), recognized 
with an antibody (Fig. 1A) or Sox2-eGFP indicator transgene (Fig. 1E) (Ellis et al., 2004) is 
expressed at low levels in the ventrolateral OE and progressively higher levels in the 
dorsomedial OE. The proneural basic helix-loop-helix transcription factor Ascl1 (formerly 
Mash1) is also expressed in a subset of dorsomedial OE cells where Sox2 levels are higher (Fig. 
1B). Conversely, Meis1 (Toresson et al., 2000) (Fig. 1C), Meis2 (not shown) and Pbx1/2/3 (Fig. 
1D) are concentrated primarily in the lateral OE (see also Fig. 2). Graded expression patterns of Sox2, Meis1 and Ascl1 appear related: Sox2 expression is typically lowest where Meis1 is 
highest (Fig. 1E). Ascl1 is seen in regions where Meis1 expression is diminished, and Sox2 
expression enhanced (Fig. 1F). Finally, in the ventromedial OE, both Meis1 and Sox2 levels are 
elevated, and Ascl1 and Pbx are not seen (Fig. 1A-D). Thus, graded transcription factor 
expression defines a primarily lateral OE domain where Meis1 is elevated, Sox2 and Pbx1 
expression varies, and Ascl1 is absent, a primarily medial domain where Ascl1 and Sox2 are 
elevated, Meis1 varies and Pbx1 is absent, and a ventro-medial domain where both Meis1 and 
Sox2 are elevated, and Ascl1 is not seen.  
Neuronal markers identify cells with morphological and molecular characteristics of ORNs, 
VRNs and GnRH neurons in the nascent OE (Fig. 1G-K). Presumptive ORNs and VRNs, labeled 
with neuronal markers such as class III β-tubulin (TuJ1) (Fig. 1G,H) and NCAM (data not 
shown) have characteristic bipolar morphologies, including an immature apical dendritic knob 
and a single axon that extends from the OE through the mesenchyme (Fig. 1H and inset). VRNs 
are distinguished by co-expression of the TrpC2 channel, which is functionally associated with 
this subclass of chemosensory neurons (Stowers et al., 2002) primarily in the presumptive 
vomeronasal organ (pVNO) (Fig. 1I and inset). Finally, GnRH neurons are found in the pVNO 
epithelium (Fig. 1J) and in the adjacent mesenchyme (Fig. 1K), migrating toward the basal 
forebrain. Neuronal labeling begins in the dorsolateral OE (Fig. 1G), where Sox2/Ascl1 levels 
increase and Meis/Pbx levels decline (Fig. 1E,F, sector c), and ends in the ventromedial OE, 
where Sox2 is elevated (Fig. 1A, left of asterisk), Ascl1 is absent and Meis levels rise. Therefore, 
at E11.5, three major classes of neurons are concentrated around the medial OE, with presumed 
ORNs in dorsolateral through dorsomedial regions, VRNs most frequent in medial to 
ventromedial domains and GnRH neurons primarily in the ventromedial OE.  Distinct modes of cell proliferation in lateral and medial OE precursors 
We next asked whether molecularly defined OE domains include precursors with distinct 
proliferative capacities. At E11.5, M-phase cells, recognized by phospho-histone 3 (PH3), are 
most frequent in the medial OE (Fig. 2A,B). PH3-labeled nuclei appear concentrated at the 
apical surface, with no apparent mediolateral differences in apical/basal distribution. Cells in the 
lateral OE are more likely to be in S-phase, based upon frequency of acutely BrdU-labeled cells 
(Fig. 2C,D). Most S-phase cells in the lateral OE also express Meis1 at high levels; however, few 
of the scattered medial OE cells that express low levels of Meis1 co-label with BrdU (Fig. 2C,D; 
see also Fig. 1C). The inverse relationship between S- and M-phase precursors suggests that cell 
cycle lengths may differ in register with molecular distinctions (Fig. 2E,F). Precursors in the 
ventromedial OE (particularly sector 1, Fig. 2E) that express Meis1, as well as high levels of 
Sox2 (Fig. 1A,C), have longer cell cycles and lower mitotic frequency, as do other Meis1-
expressing lateral precursors (especially including sectors 2-4) in which Sox2 levels decline and 
Pbx is seen (Fig. 2F). In precursors in the remaining OE sectors, where Sox2 expression is more 
robust, Ascl1 is seen, the neurons are concentrated and have shorter cell cycle times. Apparently, 
Meis1 levels may have a more substantial influence on cell cycle length than Sox2, Pbx or Ascl1 
levels.  
S-phase appears constant across the OE (Fig. 2E,F), suggesting longer cell cycles in ventral and 
lateral OE precursors reflect longer G1-S transitions. Therefore, we asked whether lateral OE 
cells are more likely to retain BrdU for long periods, a signal that is characteristic of slowly 
dividing, multipotent neural stem cells (Morshead et al., 1994). Following chronic BrdU 
exposure (E9-E11.5) and additional 5-day survival (E16.5), a significant proportion of Meis1-labeled (Fig. 2G,I-K) as well as Sox2-labeled (Fig. 2H,L-N) basal cells in the lateral OE are also 
heavily labeled with BrdU (29% Meis1 cells/87 total cells counted; 22% Sox2 cells/18 total cells 
counted; n=4 animals). We found no medial Sox2 or Ascl1 cells heavily BrdU-labeled (Fig. 
2O,P); however, a small number were faintly labeled (Fig. 2O, inset; 4% Sox2 cells/104 total 
cells counted; 2% of Ascl1 cells/83 total cells counted; n=4 animals). By contrast, a significant 
proportion of OMP-labeled ORNs in the medial OE are heavily BrdU labeled (54% OMP 
cells/31 total cells counted; n=4 animals). Thus, based upon frequency, kinetics and distribution 
of M- and S-phase markers, lateral and medial OE domains contain two distinct proliferative 
populations – one slowly dividing and another rapidly dividing – in register with differing levels 
of Meis1.  
Meis1-positive OE precursors, concentrated in the lateral OE, may divide slowly and 
symmetrically to maintain multipotent precursors while the remaining precursors, primarily 
those in the medial OE, divide rapidly and terminally to expand the neuronal population. 
Accordingly, we determined the mode and consequences of single cell divisions from E11.5 
micro-dissected lateral and medial OE using a pair cell assay (Shen et al., 2002). Pairs (two 
progeny from single OE cells after 20 hours in vitro) were classified as neuron-neuron (N-N; Fig. 
3A, top), neuron-precursor (N-P; Fig. 3A, bottom) or precursor-precursor (P-P; Fig. 3B,C) based 
upon co-labeling for TuJ1, Sox2 and bisbenzamide or for TuJ1, Meis1 and bisbenzamide. TuJ1-
positive cells were counted as neurons; Sox2- or Meis1-positive/TuJ1-negative cells were 
counted as precursors. Pairs stained with bisbenzimide only – unrecognized OE precursors, 
particularly those for non-neuronal or vascular cells, or mesenchymal cells that remain after 
incomplete removal of OE-adherent mesenchyme – were designated as precursor
*-precursor
* 
(P
*-P
*; Fig. 3D) and counted separately. The absence of Sox2 labeling in these P
*-P
* pairs suggests they are unlikely to be OE neural precursors. Meis1 (Fig. 3B) and Sox2 (Fig. 3C, top) 
pairs were found at similar frequencies in lateral OE cultures, and combined in P-P totals; medial 
cells, however, preferentially generated Sox2 pairs (Fig. 3C, bottom) and rarely labeled for 
Meis1. The primary mode of cell division for isolated lateral and medial OE precursors was 
symmetric (Fig. 3E). Lateral cells, however, generated significantly more P-P pairs (51.1±3.6% 
of 327 total lateral versus 7.6±0.4% of 251 total medial pairs from three independent 
experiments; P≤0.006, Mann-Whitney) and medial cells significantly more N-N pairs (49±2.1% 
medial versus 16.8±2.9% lateral, P≤0.006). Each region generated small percentages of N-P 
pairs (4.4±0.4% medial versus 2.8±0.7% lateral; no difference). Thus, lateral OE precursors are 
primarily self-renewing, producing additional precursors, and medial OE precursors are 
primarily neurogenic.  
Fgf8 promotes OE neurogenesis by repressing Meis1 and enhancing Sox2 
Self-renewal versus terminal neurogenesis may be regulated by exposure to inductive signals that 
influence initial OE differentiation in vitro or in vivo (Kawauchi et al., 2005; LaMantia et al., 
2000). Based on previous observations that Fgf8 enhances neurogenesis in the OE (DeHamer et 
al., 1994; Kawauchi et al., 2005; LaMantia et al., 2000), we asked whether Fgf8 increases 
symmetric neurogenic divisions in lateral OE cells at the expense of divisions favoring self-
renewal. When lateral OE precursors are treated with Fgf8, the frequency of N-N pairs increases 
twofold (Fig. 3E, bottom; 34±3.2% of 386 total pairs, three independent experiments versus 
16.8±2.9% lateral control, 51% increase, P≤0.01) and P-P pairs decline similarly (28.1±4.9 Fgf8 
versus 51.1±3.5% lateral control, 46% decline, P≤0.01). P
*-P
* pairs also increased in response to 
Fgf8 (42.9% of Fgf8 versus 29.4%, lateral control, 32% increase P≤0.045); however, this may reflect general mitogenic activity of Fgf8. Nevertheless, Fgf8 apparently enhances neurogenesis 
in lateral OE precursors from by promoting symmetrical, terminal, neurogenic divisions and 
diminishing self-renewal of precursors that express Meis1 or Sox2.  
Based on these in vitro findings, we hypothesized that Fgf8, which is available from the medial 
OE in vivo (Bhasin et al., 2003; Kawauchi et al., 2005; LaMantia et al., 2000), establishes or 
maintains OE precursor distinctions. To test this genetically, we evaluated OE precursors in 
E11.5 hypomorphic embryos, in which Fgf8 levels are significantly reduced but not eliminated 
(Fgf8
neo/neo) (Meyers et al., 1998). Fgf8
neo/neo embryos display variably penetrant phenotypes as 
previously reported (Garel et al., 2003; Meyers et al., 1998). Three out of 6 Fgf8
neo/neo embryos 
had forebrain morphogenetic defects, including rostromedial extension of ventral telencephalic 
neuroepithelium (see Fig. S1 in the supplementary material) and no morphologically identifiable 
VNO; the remainder displayed relatively normal morphologies. Altered OE transcription factor 
expression was apparent in five embryos, most noticeably in those with forebrain 
dysmorphology (Fig. 3 and see Fig. S1 in the supplementary material). Sox2 is diminished in the 
medial OE of Fgf8
neo/neo embryos (Fig. 3F), and the wild-type gradient is difficult to discern 
(compare with Fig. 1A,E). Meis1 shifts medially (Fig. 3G,J; see Fig. S1D,F,I in the 
supplementary material) but declines dorsolaterally (Fig. 3G,J) where neurons are found (Fig. 
3H). Neurogenesis, though attenuated, extends into regions where Meis1 is elevated (Fig. 3G,H). 
Ascl1 expression varies in Fgf8
neo/neo embryos (highest frequency, Fig. 3I,J; lowest frequency, 
see Fig. S1L in the supplementary material); however, remaining Ascl1 precursors appear 
diminished medially and shifted laterally (Fig. 3I; see Fig. S1F,L in the supplementary material). 
Apparently, Fgf8 promotes OE neurogenesis by enhancing Sox2 and Ascl1 expression, and 
restricting Meis1 expression.  A Sox2-dependent transcriptional network defines OE precursor identity 
OE precursors are distinguished by position-dependent expression of Sox2, Meis, Ascl1 and Pbx, 
suggesting that these transcription factors may be key regulators of their identity. Thus, we 
developed an in vitro E11.5 lateral OE preparation to ectopically express these factors and 
evaluate directly their influence on identity and neurogenic capacity (Fig. 4A). We first asked 
whether Sox2 dose regulates lateral versus medial precursor distinctions by electroporating a 
chicken β-actin/cytomegalovirus promoter that drives mouse Sox2 followed by an internal 
ribosome entry site (IRES) and eGFP (pCIG-Sox2; Fig. 4B,C). For quantification, five non-
overlapping fields were sampled ventral to the transition zone where Sox2 and Ascl1/TuJ1 levels 
rise and Meis1 levels decline (Fig. 4A). Elevated Sox2 dose elicits three cell-autonomous 
changes within the ventrolateral OE. First, ectopic overexpression of Sox2 diminishes the 
frequency of Meis1-expressing cells (93±0.48%/100 control-electroporated cells versus 
10±0.87%/100 Sox2-electroporated cells, P<0.00001; Fig. 4D-H). Second, overexpression of 
Sox2 increases the frequency of Ascl1 cells (3.1±1.18%/2217 control versus 33.1±3.06%/1585 
Sox2-electroporated cells, P<0.00002; Fig. 4I-M). Third, raising Sox2 levels enhances the 
number of TuJ1-labeled OE neurons (1.1±0.86%/2021 control cells versus 13.2±1.27%/1161 
Sox2-electroporated cells, P=0.0002; Fig. 4N-T). Thus, ectopic Sox2 overexpression imposes a 
more `medial' character on lateral OE precursors: Meis1 levels are reduced, Ascl1 expression is 
elevated and neurogenesis is enhanced.  
We next asked whether Meis or Pbx regulates acquisition or retention of `lateral' OE 
characteristics. We over-expressed Meis1 alone (pCIG-Meis1) or in combination with Pbx1 
(pCIG-Meis1-IRES-Pbx1) using a modified pCIG plasmid with an additional human EIF4G IRES (Wong et al., 2002) (Fig. 5A-C). We quantified five non-overlapping fields in the 
dorsolateral OE, dorsal to the transition zone where Sox2 levels rise, Ascl1 cells are seen, and 
Meis1 levels decline. This region contains neurons, as well as cells with more `medial' OE 
precursor characteristics (inset, Fig. 5A; see also Figs 1, 2). Ectopic elevation of Meis1, as well 
as Meis1/Pbx1, suppresses Ascl1 in dorsolateral OE cells (29±1.7% of 1632 control versus 
15.4±1.7% of 718 Meis1 cells, P=0.001; 11.8±1.2% of 860 Meis1/Pbx1 cells, P<0.00005; Fig. 
5D-I,N). There was no difference between Meis1 and Meis1/Pbx1, suggesting that Pbx co-
factors are not required for this regulatory change. By contrast, elevated Meis1/Pbx1 levels do 
not suppress Sox2 (49.8±0.7%/903 control versus 49.2±1.5%/1125 Meis1/Pbx1 cells, P=0.7; 
Fig. 5J-M,O), suggesting Meis1-mediated Ascl1 suppression is independent of Sox2. We did not 
observe a change in TuJ1-labeled neurons (data not shown). This may reflect difficulties 
detecting changes among greater concentrations of already differentiated neurons in more 
dorsolateral OE regions, or the capacity of Meis1-expressing precursors that also express high 
levels of Sox to generate neurons – perhaps at a lower frequency independent of Ascl1 – as is 
seen in the ventromedial OE. Thus, a transcriptional network defined by Sox2 dose, Meis 
activity and antagonistic regulation of Ascl1 distinguishes primarily `lateral' from primarily 
`medial' OE precursors.  
Ascl1 and Sox2 mutations yield predicted OE phenotypes 
The transcriptional network defined by Sox2, Meis1 and Ascl1 provides a framework to confirm 
genetic relationships between OE precursor classes and OE neurogenesis. If Ascl1 is crucial for 
expanding but not specifying ORN, VRN and GnRH neuron populations, loss of Ascl1 function 
in Ascl1
–/– mutant embryos should diminish but not prevent genesis of all three neuronal classes. A high medial, low lateral Sox2 gradient and a substantial population of Meis1 cells are present 
in the Ascl1
–/– OE (Fig. 6A,B). Meis1 cell frequency is somewhat higher in the mutant medial 
OE, and fewer laterally positioned Meis1 cells are acutely labeled with BrdU (Fig. 6C, compare 
with Fig. 2B), suggesting proliferative characteristics may be altered in precursors that have 
differing combinations of Sox2 as well as Meis1 expression levels in the absence of Ascl1 
function. Only a small population of TuJ1-positive OE neurons remains in the E11.5 mutant 
(Fig. 6D; 29% of wild type values; P≤0.02, n=4, Mann-Whitney); nevertheless, ORNs, VRNs 
and GnRH neurons differentiate (Fig. 6E-L). OMP-labeled ORN frequency, however, is 
diminished by E16.5 (Fig. 6M). The small compliment of ORNs probably reflects limited early 
neurogenesis that declines to undetectable levels within 1 day of terminal division of an initial 
precursor cohort (Fig. 6I-N).  
In our electroporation experiments, we found that elevated Sox2 suppresses Meis1 and promotes 
Ascl1 as well as neurogenesis (Fig. 4); therefore, it seemed that reduced Sox2 dose in vivo 
(Sox2
hyp/–) (Taranova et al., 2006) should expand Meis1, reduce or eliminate Ascl1, and diminish 
neurogenesis. Indeed, cells expressing Meis1/2 as well as Pbx genes are seen throughout the 
Sox2
hyp/– OE (Fig. 7A-D; data not shown). Ascl1 cells are absent in the OE (Fig. 7E) but seen in 
the ventral forebrain (Fig. 7E, inset). S- and M-phase frequency declines in parallel with Meis1 
precursor expansion (Fig. 7F-H). The number of TuJ1 neurons generated by E11.5 is 
significantly less than wild type (20%; P≤0.02, n=4, Mann-Whitney; Fig. 7I), similar to Ascl1
–/– 
OE values. Reduced neuronal differentiation and failed VNO morphogenesis in Sox2
hyp/– 
embryos parallels that in Fgf8
neo/neo embryos (Fig. 3 and see Fig. S1D in the supplementary 
material), suggesting a relationship between Fgf8 signaling, Sox2 dose, VNO morphogenesis and 
OE neurogenesis. Nevertheless, all neuronal classes generated by the OE – ORNs, VRNs and GnRH neurons – are seen in the Sox2
hyp/– at E11.5 as well as at E6.5 (Fig. 7J-L). Thus, Sox2 dose 
is crucial for restricting Meis1 in the lateral OE, enhancing Ascl1 in the medial OE, and 
sustaining genesis – but not specification – of ORN, VRN and GnRH neurons.  
DISCUSSION 
We identified distinct precursor populations in the nascent OE that comprise self-renewing 
neural stem cells as well as transit amplifying cells that give rise to ORNs, VRNs and GnRH 
neurons. Meis1-expressing OE precursors, primarily in the lateral OE where neurons are absent 
or sparse, proliferate slowly and symmetrically to generate additional precursors. Proliferative 
cells that express high levels of Sox2, as well as Ascl1, primarily in the medial OE among 
differentiating neurons, divide rapidly and symmetrically to expand the OE neuronal population. 
Meis1, Sox2 and Ascl1 define a novel transcriptional network that regulates progression between 
these precursor states. Sox2 dose, controlled in part by local Fgf8 signaling, promotes OE 
neurogenesis by suppressing Meis1 and enhancing Ascl1 expression. Elevated Meis gene dose, 
independent of Pbx co-factors, diminishes Ascl1, but not Sox2 expression, and reduces 
neurogenesis by maintaining a more `lateral' precursor identity. This Fgf8-regulated, dose-
dependent network balances self-renewal and terminal neurogenesis in the early embryonic OE.  
Transcriptional profiles for OE precursors 
Transcription factor profiles distinguish slowly dividing self-renewing from rapidly dividing 
transit amplifying OE precursors (Fig. 8A). As in other CNS regions, including the cerebral 
cortex (Bani-Yaghoub et al., 2006; Schuurmans and Guillemot, 2002), spinal cord (Graham et 
al., 2003) and retina (Heine et al., 2008; Taranova et al., 2006), OE precursors express SoxB1, Meis and bHLH genes (Fig. 8A). Our analysis, although not exhaustive, illustrates that OE 
precursor classes are not identified by singular expression of any factor. Instead, relationships 
between graded expression – suggesting dose effects – define OE precursor identity. This 
expression-based identity of OE precursors corresponds approximately to `lateral' and `medial' 
OE regions; however, transcription factor gradients do not strictly respect these anatomical 
boundaries. Indeed, transition zones in the ventromedial as well as dorsolateral OE have cells 
with combinations of factors that may further distinguish proliferative capacity or fate; 
accordingly, there may be additional precursor classes than those defined here. Such 
observations may complicate planning or interpreting OE `transcriptional fate mapping' studies 
using recombination driven by single transcription factor loci: few OE precursors uniquely 
express any particular factor. Thus, alternative approaches may be needed to map OE lineages 
and fates, including local tracer injections combined with conditional recombination-based 
approaches.  
Fgf8 and Sox2 act synergistically in the developing OE 
The inductive signal Fgf8 and the transcription factor Sox2 regulate OE precursor identity and 
neurogenic capacity (Fig. 8B,C). Elevated Fgf8 levels alone are sufficient to elicit terminal 
symmetric neurogenic division from isolated `lateral' OE precursors – making them resemble 
`medial' OE precursors. When Fgf8 is reduced in the early OE by hypomorphic mutation, 
patterning is disrupted: Sox2 and Ascl1 levels decline, and Meis1 levels expand. Apparently, 
when Fgf8 is diminished, these cells acquire `lateral' precursor characteristics. The identity of 
`medial' OE precursors, and parallel morphogenesis of medial structures such as the VNO 
probably depend on maintaining high Sox2 levels, which in turn depend upon normal levels of Fgf8. Accordingly, both Fgf8 and Sox2 hypomorphic OE phenotypes include Meis expansion, 
diminished Ascl1, failed VNO morphogenesis (without complete loss of the VRN marker 
TrpC2) and diminished neurogenesis (see also Kawauchi et al., 2005), without apparent loss of 
distinct OE neuron classes. Thus, precursors in Fgf8 and Sox2 hypomorphs – mostly expressing 
Meis1 – must include fate-specified multipotent OE neural stem cells.  
A Sox2 dose-dependent transcriptional network defines OE precursors 
We defined a transcriptional network that regulates progression of slowly dividing self-renewing 
to rapidly dividing terminal neurogenic OE precursors (Fig. 8B,C). Our results place Sox2 at a 
crucial, but distinct, position in specification of peripheral chemosensory versus other sensory 
receptor lineages, including hair cells (Dabdoub et al., 2008), taste cells (Okubo et al., 2006) and 
retinal precursors (Taranova et al., 2006). In contrast to Sox2 function in the ear, tongue and eye, 
where dose influences genesis of differentiated neuron subclasses, Sox2 in the nose is a 
concentration-dependent regulator of precursor state for the entire OE neuronal lineage. Direct 
electroporation in vitro as well as genetic manipulation in vivo indicates that low Sox2 dose 
maintains Meis1-expressing OE precursors. High Sox2 dose, modulated by Fgf8, facilitates the 
transition to terminally neurogenic precursors by inhibiting Meis1 and promoting Ascl1. Thus, 
Sox2 and Meis1 antagonistically (but not fully reciprocally; Fig. 8C) regulate Ascl1, which 
governs quantitative neurogenic output, but not identity, in the OE. As in the retina (Taranova et 
al., 2006), higher Sox2 dose might also modulate Notch and Hes expression or activity in the 
medial OE (Carson et al., 2006; Cau et al., 2000; Schwarting et al., 2007); however, it may be 
difficult to distinguish Sox2 and bHLH function in Notch-dependent mechanisms (Cau et al., 
2000).  Sox2 dose is a crucial regulator of OE precursors via its influence on Meis genes. Elevated Sox2 
in the lateral OE in vitro results in an effective local loss of Meis1 and Ascl1. We confirmed the 
relationship between Sox2 and Ascl1 in vivo using Fgf8
neo/neo and Asc1
–/– mutants; however, 
evaluating this relationship for Meis1, independent of Sox2 manipulation, remains challenging. 
We found no molecular, proliferative or neuronal defects in the OE of E11.5 Meis1
–/– embryos 
(data not shown), perhaps because Meis1, Meis2 and Meis3, which are apparently redundant in 
other systems (Hisa et al., 2004), are co-expressed in the developing OE. Nevertheless, the 
effective gain of Meis1 function in the Sox2
hyp/– OE reinforces the relationship between Sox2, 
Meis1 and Ascl1, and is consistent with dose-dependent influences of Sox2 on distinct OE 
precursor classes.  
Meis1 OE precursors and OE neural stem cells 
In the OE, Meis1 supports slowly dividing self-renewing precursors, whereas in retinal (Heine et 
al., 2008) and myogenic precursors (Berkes et al., 2004), it influences rapidly proliferating 
terminal-differentiating transit-amplifying precursors, perhaps via interactions with Pbx/Hox, 
bHLH genes and other factors. This suggests a novel function for Meis genes in the OE: 
suppression of bHLH genes to maintain slowly dividing self-renewing multipotent stem cells. 
Meis1-expressing OE precursors (Fig. 8B) conform to many criteria that define tissue-specific 
stem cells. They undergo slow symmetric self-renewing cell divisions (Gage, 2000; Slack, 2000), 
are found in a `niche' or distinct location (Fuchs et al., 2004; Moore and Lemischka, 2006), and 
generate all differentiated cell classes in a particular tissue. No other OE precursors have these 
characteristics, including capacity for `label retention' that distinguishes stem cells in other 
epithelia (Borthwick et al., 2001; Cotsarelis et al., 1990; Wong and Wright, 1999). Finally, ORNs, VRNs and GnRH neurons are seen in Ascl1
–/– and Sox 2
hyp/– mutants, in parallel with 
expanded or potentially exclusive presence of Meis1-expressing precursors. This argues strongly 
that Meis1 OE precursor populations include fate-specified stem cells that yield all major types 
of OE neurons. We cannot, however, rule out additional heterogeneity among Meis1 precursors 
that leads to diversity of potential and fate as is the case for early retinal progenitors (for a 
review, see Marquardt and Gruss, 2002).  
The lateral OE, perhaps owing to antagonism between lateral RA and medial Fgf8 signaling in 
the context of mesenchymal/epithelial (M/E) interaction (Bhasin et al., 2003; LaMantia et al., 
2000), may provide a specific niche that maintains a substantial population of Meis1-expressing 
precursors. Only frontonasal M/E interactions establish this niche – probably owing to distinctive 
RA-producing neural crest that constitutes the lateral frontonasal mesenchyme (Anchan et al., 
1997; LaMantia et al., 2000). Indeed, in vitro, excess RA diminishes Sox2 in the medial OE, 
whereas excess Fgf8 increases Sox2 in the lateral OE (Rawson et al., 2010). When Meis1 
induction fails in the presumptive OE in vitro, due to altered M/E interactions (Rawson et al., 
2010), neurons are generated, but ORNs, VRNs and GnRH neurons do not differentiate. The role 
of Meis1 OE precursors in generating non-neural supporting cells, which appear later in 
development (Asson-Batres and Smith, 2006), or ensheathing cells that migrate from the OE 
(Doucette, 1989) remains to be evaluated. Nevertheless, slowly dividing multipotent neural stem 
cells capable of generating ORNs, VRNs and GnRH neurons must be included among Meis1-
expressing precursors found primarily in the lateral OE.  Defining OE neural stem cells throughout life 
Our data provide new guidance for identifying adult OE neural stem cells, which have remained 
elusive despite their central importance in regeneration after OE injury (Nordin and Bramerson, 
2008), and in psychiatric and neurodegenerative diseases (Feron et al., 1999; Hahn et al., 2005; 
Johnson et al., 1994). The distinct characteristics of embryonic OE precursors focus attention not 
only on molecular markers for adult counterparts, but on locations for a supportive niche, similar 
to those in other mature regenerating epithelia, including gut, lung and – in lower vertebrates – 
the retina (Borthwick et al., 2001; Hitchcock et al., 2004; Wong and Wright, 1999). If OE axes 
are systematically transformed between the embryo and the adult, neural stem cells should be 
sought along the lateral OE boundary with the respiratory epithelium. In this location, secreted 
factors (including RA) may maintain multipotent OE neural stem cells and antagonize signals 
involved in ORN maturation and zonal specification (Norlin et al., 2001). Indeed, cultures from 
human OE biopsies at this boundary generate cells with molecular and functional characteristics 
of ORNs (Borgmann-Winter et al., 2009). Thus, our results may facilitate study of nervous 
system regeneration, and provide insight into pathobiology of diseases that compromise olfaction 
as part of a broader spectrum of nervous system dysfunction.  
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Fig. 1.  
Molecularly distinct domains in the E11.5 mouse OE. (A) Graded Sox2 expression is highest 
in the medial presumptive vomeronasal organ (pVNO), and lowest ventrolaterally (asterisk). (B) 
Ascl1 is expressed from the dorsolateral OE through medial pVNO region (between 
arrowheads), mostly overlapping high Sox2 expression; arrow indicates non-specific basal 
lamina labeling. Inset: higher magnification of the boxed region shows Ascl1-positive nuclei. (C) 
Meis1 expression begins ventromedially, peaks in the lateral OE and declines dorsolaterally. 
Inset: higher magnification of region boxed shows nuclear Meis1 in nascent TuJ1-labeled OE 
neurons. (D) Pbx1/2/3 is expressed in the lateral OE and, like Meis1 expression, declines 
dorsally. (E) Graded expression of Sox2 (Sox2-eGFP reporter) and Meis1 is complementary. 
There is a sharp ventral boundary (box, inset). a-e indicate the levels of sections shown in the 
panels on the right. Varying levels of complementary Sox2 and Meis1 expression are found in 
cells at distinct ventrolateral (a) to dorsomedial (e) locations. Little if any Meis1 is seen dorsally 
(e) where Sox2 predominates. (F) Ascl1 and Meis1 are also complementary; however, robust 
Ascl1 labeling begins only in dorsomedial locations (d, e, right panels), where Meis1 is nearly 
undetectable. (G) TuJ1-labeled OE neurons are seen at low frequency dorsolaterally, become 
concentrated dorsomedially through the pVNO and decline to a few scattered cells in the extreme 
ventromedial OE (asterisk). Box indicates region shown in H. (H) TuJ1-labeled OE neurons 
have cytological hallmarks of ORNs and VRNs: a single apical process (asterisk), apparent 
`dendritic knob' (inset) and a single axon (arrowhead). (I) VRNs are distinguished by enhanced 
expression of TrpC2 (red) within the pVNO (between arrowheads), apparently on the cell surface 
of TuJ1-labeled neurons (green, inset). (J) GnRH neurons are seen within, or ventral to, the 
pVNO. Inset: higher magnification of boxed region, showing two GnRH neurons within the 
ventromedial OE. (K) GnRH neurons delaminate from the OE (arrow, e) and migrate through the 
frontonasal mesenchyme (arrowheads, m).   
Fig. 2.  
OE precursors have distinct proliferative characteristics. (A) PH3 labeled cells (M-phase) 
are less frequent in lateral versus medial OE. (B) Counts of PH3 cells in 10 geometrically 
defined OE s	 ﾠ ectors (positions are indicated in A) confirm enhanced M-phase cell frequency in 
dorsomedial versus ventrolateral regions. (C) Acute BrdU labeling increases ventro- to 
dorsolaterally, and declines in register with diminishing levels of Meis1. (Insets) There are 
scattered cells lightly labeled with Meis1 (e.g. asterisk in sector 4 image) in medial regions 
(sectors 6-10). (D) Counts of BrdU, Meis1 and double-labeled cells in 10 equivalent OE sectors 
(positions are indicated in A) confirm inverse Meis1 and S-phase frequency. We counted lightly 
Meis1 labeled cells (
* in panel 4), yielding a lower frequency of Meis1 cells especially in sectors 
7-10. (E) Cell cycle times estimated using dual S-phase labeling. IdU/BrdU-labeled cells 
(yellow), BrdU-alone (green) and all cells (bisbenzimide; not shown) are counted to calculate 
cell cycle time (Tc) and S-phase duration (Ts). (F) Tc and Ts in OE sectors 1-10 (positions are 
indicated in E). (G) Precursors that retain BrdU for long periods (5 days, `label-retaining') are 
found in lateral E16.5 OE and express Meis1. (H) Similar label-retaining lateral precursors 
express Sox2. (I-K) A single cell in separate color channels shows nuclear, BrdU, and Meis1 
labeling. (L-N) A similar color separation of a label-retaining cell confirms nuclear Sox2 
expression. (O) Heavily BrdU-labeled medial cells (arrowheads) do not coincide with high Sox2 
cells in medial E16.5 OE. Inset: higher magnification of boxed area shows an example of a 
lightly BrdU-labeled high Sox2-expressing medial OE cell. (P) Label-retaining medial cells 
rarely if ever coincide with Ascl1 in the medial E16.5 OE. (Q) Many heavily BrdU-labeled 
medial cells at E16.5 are ORNs, based upon dual labeling with the ORN marker OMP.   
Fig. 3.  
OE precursors have distinct modes of division and Fgf8-dependent neurogenic potential. 
(A-D) Examples of neuron (TuJ1 N, nuclear counterstain with bis-benzamide), precursor (Meis1 
or Sox2, P) or nuclear (bisbenzamide only, P
* pairs cultured from microdissected lateral and 
medial E11.5 OE. (E) Histograms show frequency of N-N (green, TuJ1 labeled), N-P (green-red, 
TuJ1 and Sox2 or Meis1), P-P (red, Meis1 or Sox2 labeled) or P
*-P
*(bis-benzamide only) pairs 
from lateral (top) and medial OE cells (middle). Bottom histogram shows influence of exogenous 
Fgf8 added to the culture medium on frequency of pairs generated by lateral OE cells. (F-J) In 
vivo consequences of reduced Fgf8 levels shown for two Fgf8 hypomorphic mouse embryos. (F) 
Sox2 levels are diminished in the medial OE, and a distinct mediolateral gradient is difficult to 
discern. (G) Meis1 expression diminishes in the dorsolateral OE (bracket), but expands into the 
medial OE (arrow). (H) TuJ1-positive neurons are reduced medially (arrow) and shifted laterally 
(bracket). (I) Ascl1-positive precursors diminish in the medial OE and shift laterally, matching 
TuJ1 distribution in the hypomorphic OE. (J) Meis1 and Ascl1 double-labeling shows medial 
loss of Ascl1 and coincident expansion of Meis1 (arrow), as well as Ascl1 lateral expansion 
where Meis1 declines (bracket).   
Fig. 4.  
Sox2 dose regulates OE precursor identity. (A) 
Schematic of E11.5 lateral OE explant 
electroporation, culture and sampling strategy. 
Confocal images show (B) control eGFP or (C) 
pCIG-Sox2-electroporated lateral OE. Boxed areas 
in all panels indicate regions examined for 
illustration and quantification. Lower (D,E) and 
higher (F,G) magnification confocal images show 
Meis1 co-expression (cyan, arrows) or lack thereof 
(asterisks) in control (D,F) or Sox2-electroporated 
(E,G) GFP-positive (green) OE cells. (H) Effects 
of elevated Sox2 dose on Meis1 cell frequency. 
Lower (I,J) and higher (K,L) magnification 
images show lack of Ascl1 expression (asterisks) 
in control cells (I,K) and enhanced Ascl1 
expression (red, arrows) in Sox2-electroporated 
(J,L) cells. (M) Effects of elevated Sox2 dose on 
Ascl1 cell frequency. Confocal images show TuJ1-
labeled neurons in control (N) and Sox2-
electroporated (O) lateral OE. Lower (P,Q) and 
higher (R,S) magnification images show lack of 
coincidence (asterisks) with TuJ1 neurons (red) in 
control (P,R) or an increase (arrows) in Sox2-
electroporated (Q,S) cells. (T) Effects of elevated 
Sox2 dose on TuJ1-labeled neuron frequency. (U) 
Higher magnification images show a Sox2-
electroporated TuJ1-labeled neuron with a single 
apparent axon. 
*P≤0.0002.  
	 ﾠ 
Fig. 5.  
Meis1 regulates OE precursor identity. (A-C) Confocal images show E11.5 lateral OE 
preparations electroporated with control (A), pCIG-Meis1 (B) or pCIG-Meis1-IRES-Pbx1 (C) 
and labeled for Ascl1. Inset in A shows area illustrated and sampled for Meis1 overexpression 
experiments. Boxed areas represent regions used for illustration and quantification. Lower (D-F) 
and higher (G-I) magnification comparison of Ascl1 expression in control (D,G), Meis1 (E,H) or 
Meis1/Pbx1 (F,I) electroporated cells in the dorsolateral OE. (J,K) Images showing E11.5 
control (J) and Meis1/Pbx1 (K) electroporated preparations labeled for Sox2. (L,M) Sox2 is seen 
in control (L) and Meis1/Pbx1 (M) electroporated cells in the dorsolateral OE. (N) Frequency of 
GFP-Ascl1 doubled-labeled cells in control, Meis1 and Meis1/Pbx1 electroporated preparations. 
(O) Frequency of GFP-Sox2 double-labeled cells in control and Meis1-Pbx1 electroporated 
preparations. 
**P≤0.002; 
***P≤0.0002.   
Fig. 6.  
Precursor and neuron identity in the Ascl1
–/– mutant OE. (A) The Sox2 medial-lateral 
gradient is preserved in the E11.5 OE. (B) Heavily labeled Meis1 cells remain concentrated in 
the lateral OE in Ascl1
–/– E11.5 mouse embryos, whereas moderately labeled cells expand 
medially. (C) Frequency and distribution of Meis1 cells, acutely labeled BrdU cells and 
Meis1/BrdU double-labeled cells is altered in the Ascl1
–/– OE. Positions of the cells are indicated 
in B. (D) Limited neuronal differentiation, recognized with TuJ1, is seen in the E11.5 Ascl1
–/– 
OE. (E) TrpC2 (red) expression can still be detected in a small subset of Ascl1
–/– OE neurons 
(green). (F,G) OMP and the ORN-selective adenylyl cyclase ACIII (green) are expressed and 
localized appropriately in Ascl1
–/– ORNs at E16.5. (H) GnRH neurons are generated in or near 
the pVNO in Ascl1
–/– embryos. (I-L) ORNs in the E16.5 Ascl1
–/– OE are birthdated with BrdU at 
E10 (earliest ORN genesis; I, J) and E11 (K,L). (M) Frequency of OMP-positive ORNs in the 
E16.5 Ascl1
–/– OE is substantially reduced. (N) Near-normal frequency of ORN genesis at E10 
declines to near zero by E11 in the E16.5 Ascl1
–/– OE. 
*P≤0.02.   
Fig. 7.  
Precursor and neuron identity in the Sox2
hyp/– OE. (A-D) Meis1 cells are distributed 
throughout the OE over the entire anteroposterior axis in Sox2
hyp/– mouse embryos. (E) Ascl1 is 
not detected in Sox2
hyp/– OE, but is seen in MGE precursors in the forebrain (Inset). (F) Acute 
BrdU labeling is substantially diminished in Sox2
hyp/– OE. Scattered BrdU-positive cells are 
nevertheless detectable (inset). (G,H) Frequency of PH3-labeled mitotic cells diminishes towards 
lateral values in dorsomedial sectors of the Sox2
hyp/– OE. The positions of the cells are indicated 
in G. (I) Neuronal differentiation is attenuated in the Sox2
hyp/– OE. TuJ1-labeled neurons are seen 
dorsally (arrowheads) and their frequency is diminished (compare with Fig. 1G). (J) TrpC2 
remains expressed in the E11.5 Sox2
hyp/– OE. Arrowheads indicate the dorsomedial OE where 
both TuJ1- and TrpC2-labeled neurons are seen in the Sox2
hyp/–.(K) A small number of ORNs 
that express OMP (red) and ACIII (green, inset) differentiate by E16.5 in the Sox2
hyp/– OE. 
Arrowheads indicate the dendritic knob of an OMP-labeled ORN in the Sox2
hyp/– OE. Inset is at 
higher magnification showing that ACIII is localized to this dendritic knob, as in wild-type E16.5 
ORNS (see Fig.6F). (L) GnRH neurons are still detected, although at lower frequencies, in the 
Sox2
hyp/– OE, adjacent mesenchyme (m) and ventral forebrain (fb). The lower inset shows 
GnRH-labeled cells in the OE (e), as well as the adjacent mesenchyme (m) of the E11.5 Sox2
hyp/–
. The upper inset shows several GnRH-labeled cells in the frontonasal mesenchyme (m).   
Fig. 8.  
Distinct molecular and cellular identities of OE precursors. (A) Precursor identity is 
established by OE position and reflected in combinatorial graded transcription factor expression. 
(B) Meis1 defines slowly dividing self-renewing precursors, primarily in the lateral OE; 
enhanced Sox2, coincident with Ascl1 and increased Fgf8 signaling, identifies transit amplifying 
precursors, primarily in the medial OE, that are responsible for quantitative expansion, but not 
specification of ORNs, VRNs and GnRH neurons. Slowly dividing precursors in the ventro-
medial OE express both Meis1 and Sox2 at high levels (A), and may contribute to genesis of 
GnRH cells and/or VRNs, which populate this region. (C) A Sox2 dose-dependent 
transcriptional network, modulated by Fgf8, preserves lateral slowly dividing, multipotent OE 
precursors by maintaining low Sox2 levels that support Meis1 expression, or promotes medial 
transit amplifying cells that expand OE neuron numbers by Fgf8-dependent high Sox2-mediated 
downregulation of Meis1 and parallel upregulation of Ascl1.  
 Fig. S1. Mediolateral patterning defects in the hypomorphic Fgf8 olfactory epithelium. (A) 
Frontonasal process of wild-type Fgf8 littermate stained with TuJ1 (green), Meis1 (red), and 
bisbenzimide (blue). (B) Higher magnification of box in A showing normal lateral restriction of 
Meis1 domain, and prominent neuronal differentiation in the medial OE. (C-L) Three 
independent Fgf8
neo/neo mutant embryos show similar patterning deficits, failed pVNO 
morphogenesis and abnormal forebrain development, including rostromedial protrusion of 
ventral telencephalic tissue (arrows). (C) Frontonasal process of an Fgf8 hypomorph stained as in 
A. (D) Higher magnification of box in C showing medial expansion of Meis1 (arrowhead) and 
accompanying loss of TuJ1-positive neurons in the medial OE. (E) Frontonasal process of 
second Fgf8 hypomorph stained with Ascl1 (green), Meis1 (red) and bisbenzimide (blue). (F) 
Higher magnification of box in E showing medial expansion of Meis1 (arrowhead) and reduction 
in Ascl1 labeling in the medial OE. (G,H). Third Fgf8 hypomorph at two positions (2, 5) along 
the anteroposterior axis recapitulated in I-L. (I) Meis1 expression is shifted medially 
(arrowheads), particularly at rostral levels, of the nascent OE. (J) TuJ1 staining is reduced in the 
medial OE in register with medial expansion of Meis1. (K) Sox2 levels are reduced medially, 
leveling its medial-high/lateral-low graded expression pattern throughout the entire AP axis of 
the OE. (L) Ascl1 expression is reduced and fewer brightly labeled nuclei are present in the 
medial OE.	 ﾠ	 ﾠ
 